|
Anum Zahra Epidemiologist Email: Social: - |
Background
Anum Zahra is a medical doctor from Rawalpindi Medical University, Pakistan. She pursued a Master’s in Epidemiology at the London School of Hygiene & Tropical Medicine, followed by a postgraduate Master’s in Clinical Epidemiology from Utrecht University. She completed her PhD within department of Epidemiology and Health Economics at the Julius Center, University Medical Center Utrecht, with her thesis titled "Prediction Modeling in Older Adults: Insights from the COVID-19 Pandemic."
Currently, Anum is working as Epidemiologist at the department of Medical Informatics at the Erasmus M.C. contributing to the DARWIN EU® project.
Publications
- Zahra A, Luijken K, Abbink EJ, van den Berg JM, Blom MT, Elders P, Festen J, Gussekloo J, Joling KJ, Melis R, Mooijaart S, Peters JB, Polinder-Bos HA, van Raaij BFM, Smorenberg A, la Roi-Teeuw HM, Moons KGM, van Smeden M; COOP Consortium. A study protocol of external validation of eight COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting. Diagn Progn Res. 2023 Apr 4;7(1):8. doi: 10.1186/s41512-023-00144-2. PMID: 37013651; PMCID: PMC10069944.
- Zahra A, van Smeden M, Abbink EJ, van den Berg JM, Blom MT, van den Dries CJ, Gussekloo J, Wouters F, Joling KJ, Melis R, Mooijaart SP, Peters JB, Polinder-Bos HA, van Raaij BFM, Appelman B, la Roi-Teeuw HM, Moons KGM, Luijken K. External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting. J Clin Epidemiol. 2024 Apr;168:111270. doi: 10.1016/j.jclinepi.2024.111270. Epub 2024 Feb 2. PMID: 38311188.
- van Raaij BFM*, A Zahra*, Steyerberg EW, de Hond AAH, Smits RAL, van der Klei VMGTH, Polinder-Bos HA, Minnema J, Appelman B, Smorenberg A, Trompet S, Peeters G, van Smeden M, Moons KGM, Gussekloo J, Mooijaart SP, Noordam R; COOP consortium; COVID-OLD study. The influence of the dynamic context of the pandemic on the predictive performance of mortality predictions over time in older patients hospitalized for COVID-19. J Clin Epidemiol. 2025 Mar;179:111652. doi: 10.1016/j.jclinepi.2024.111652. Epub 2024 Dec 26. PMID: 39732182.
- Zahra A, van Smeden M, Elders PJM, Festen J, Gussekloo J, Joling KJ, van Loon A, Luijken K, Melis RJF, Mooijaart SP, Moons KGM, Peeters G, Polinder-Bos HA, Wouters F, de Hond A. Charlson comorbidity index has no incremental value for mortality risk prediction in nursing home residents with COVID-19 disease. BMC Geriatr. 2025 Jan 30;25(1):67. doi: 10.1186/s12877-025-05721-2. PMID: 39885429; PMCID: PMC11780814.
- Zahra A*, and van Raaij BFM*, van Smeden M, Gupta RK, Gussekloo J, Luijken K, Moons KGM, Mooijaart SP, Noordam R, de Hond A, on behalf of the COOP consortium and COVID-OLD study group. Is frailty incremental to the 4C Mortality model for mortality risk prediction in hospitalized older individuals with COVID-19 disease?
- la Roi-Teeuw HM, van Royen FS* and de Hond A* and Zahra A*, de Vries S, Bartels R, Carriero AJ, van Doorn S, Dunias ZS, Kant I, Leeuwenberg T, Peters R, Veerhoek L, van Smeden M, Luijken K. Don't be misled: 3 misconceptions about external validation of clinical prediction models. J Clin Epidemiol. 2024 Aug;172:111387. doi: 10.1016/j.jclinepi.2024.111387. Epub 2024 May 8. PMID: 38729274.